Canaccord Genuity Starts Savient Pharmaceuticals (SVNT) at Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 15 | New: 34
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 15 | New: 34
Join SI Premium – FREE
Canaccord Genuity initiates coverage on Savient Pharmaceuticals (NASDAQ: SVNT) with a Hold. PT $2.00.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.13 yesterday.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Starts Centrus Energy Corp. (LEU) at Buy
- AmerX Starts Netskope (NTSK) at Hold
- JPMorgan Starts Travel + Leisure (TNL) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
